Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00044213 · ClinicalTrials.gov registry record · Phase 3
Trial to Assess Chelation Therapy (TACT)
A Phase 3 study, sponsored by Mt. Sinai Medical Center, Miami.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,708
- Enrollment target
NCT00044213 is a Phase 3 study that has completed, run by Mt. Sinai Medical Center, Miami. The registered enrollment target is 1,708 participants.
The verdict
NCT00044213, a Phase 3 study, has completed, sponsored by Mt. Sinai Medical Center, Miami.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,708 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the safety and effectiveness of ethylene diamine tetra-acetic (EDTA) chelation therapy in individuals with coronary artery disease.
Interventions
- DRUG EDTA
- DRUG EDTA Placebo
- DIETARY_SUPPLEMENT High Dose Vitamin
- DIETARY_SUPPLEMENT High Dose Vitamin Placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,708 participants |
| Start Date | 2003-09 |
| Est. Completion | 2012-08 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00044213
The ClinicalTrials.gov registry entry for NCT00044213 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 1,708 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mt. Sinai Medical Center, Miami, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which EDTA is the first listed.
NCT00044213 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00044213 about?
NCT00044213 is a clinical study titled "Trial to Assess Chelation Therapy (TACT)". The purpose of this study is to determine the safety and effectiveness of ethylene diamine tetra-acetic (EDTA) chelation therapy in individuals with coronary artery disease.
What is the current status of trial NCT00044213?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,708 participants. The study started on 2003-09. Estimated completion is 2012-08.
What interventions are being tested in trial NCT00044213?
The interventions under investigation include: EDTA (DRUG), EDTA Placebo (DRUG), High Dose Vitamin (DIETARY_SUPPLEMENT), High Dose Vitamin Placebo (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00044213?
This trial is sponsored by Mt. Sinai Medical Center, Miami, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.